Two Sigma Advisers »

Cartesian Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $179k 25k 7.21

More positions owned by Two Sigma Advisers

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Micron Technology (MU)
Palantir Technologies Cl A (PLTR)
Charles Schwab Corporation (SCHW)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Intuitive Surgical Com New (ISRG)
Boston Scientific Corporation (BSX)
Lockheed Martin Corporation (LMT)
Adobe Systems Incorporated (ADBE)

View all positions for Two Sigma Advisers

Top funds holding Cartesian Therapeutics

FMR
BlackRock
Vanguard Group
683 Capital Management
Erste Asset Management GmbH
Geode Capital Management
State Street Corporation
Marshall Wace
Privium Fund Management B.V.
Millennium Management
Jacobs Levy Equity Management
Two Sigma Investments
Northern Trust
Citadel Advisors
GSA Capital Partners

View all funds holding Cartesian Therapeutics